⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SNY News
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
Recludix Pharma Bolsters Scientific Advisory Board with Acclaimed Leaders in the Fields of Rheumatology, Dermatology and JAK/STAT Biology
globenewswire.com
SCLZ
LLY
SNY
$21.93 Bn Colorectal Cancer Drugs Global Market Trends, Opportunities and Strategies, 2019-2024, 2025-2029F, 2034F
globenewswire.com
MRK
AMGN
BMY
LLY
TAK
PFE
SNY
Diagonal Therapeutics Announces Oversubscribed $125 Million Series B Financing to Advance Clinical Development of Disease-Modifying, Clustering Antibody Pipeline
globenewswire.com
SNY
Psoriasis Market to Exhibit Growth at a CAGR of 1.7% During the Forecast Period (2025-2034), Owing to Continuous Innovation in Biologic Therapies and Approval of Oral Small Molecules | DelveInsight
prnewswire.com
TAK
JNJ
CANF
AMGN
ABBV
NVS
BMY
AZN
BHC
LLY
UCB
LEO
REGN
XBI
IBB
JAZZ
MRK
SNY
GILD
INCY
PFE
LULU
PRTH
DRH
BIIB
TEVA
ARCT
HRMY
CRSP
NTLA
EDIT
SNOW
DDOG
CRM
GOOG
MSFT
AAPL
AMZN
TSLA
NVDA
META
NFLX
DIS
CMCSA
VZ
T
KO
PEP
MCD
SBUX
HD
EXAS
ILMN
BNTX
MRNA
XOM
CVX
BA
CAT
GE
IBM
INTC
CSCO
ADBE
QCOM
AMAT
MU
ORCL
ACN
COST
WMT
TGT
LOW
HON
GD
LMT
RTX
BAX
BrightInsight’s Patient App, developed with Sanofi, shows positive impact in patient treatment adherence and persistence
globenewswire.com
SNY
REGN
Recludix Pharma to Present at the Annual J.P. Morgan Healthcare Conference
globenewswire.com
LLY
SNY
Enable Injections Announces $30 Million Investment from Sanofi to Accelerate Manufacturing Capabilities
globenewswire.com
SNY
Clarivate Identifies Eleven Potential Blockbuster and Transformative Therapies in its 2026 Drugs to Watch Report USA - English India - English
prnewswire.com
CLVT
LLY
GSK
JNJ
SNY
CELC
CRBP
BMY
NOVUS Names Libby Morgan Chief Executive Officer to Lead Next Phase of Growth
prnewswire.com
HPQ
SNY
Why Respiratory Vaccines Remain a Strategic Focus for Healthcare Systems Worldwide?
globenewswire.com
PFE
MRNA
GSK
SNY